Human Edge, a longevity science company, has announced that it has raised over USD 1.5M in new equity financing. The investment was led by Bharat Innovation Fund, along with Lead Angels and Force Ventures and a number of strategic angel investors from Singapore, USA, and India.
Founded by Marcus Ranney in late 2020, a prominent healthcare advocate and a thought leader on the international stage, Human Edge approaches longevity via enhancing healthspan using science, deep data and technology based lifestyle interventions. The company is building a proprietary platform for empowering its users to engage in daily “biohacks”- small, actionable, lifestyle based modifications that focus on optimizing a person’s energy levels towards meeting a specific health outcome. These biohack “prescriptions'' are personalized based on a user sharing data with the Human Edge platform which is a combination of assessments, blood panels and real time digital streams from consumer tech wearables like the Oura ring, Abbott’s Continuous Glucose Monitor, Apple Watch, Fitbit band and many more. This data is cumulated to generate a composite healthspan score, called the 'Human Edge Index'.
Speaking on behalf of Bharat Innovation Fund, an India based deep tech fund that led the round, Cofounder and Partner Ashwin Raguraman said, “The human body generates a tremendous amount of data, which if used effectively to modify our behaviour, can lead to a better quality of life. The proliferation of wearable devices means that we now have access to data. Human Edge’s technology enables us to interpret that data effectively and provides each of us with a clear call to action on that data, to improve our metabolic health and overall well-being. We are delighted that our partnership with Human Edge helps us support Marcus Ranney bring his pioneering work in high performance environments to a larger audience and provide clinically backed actionable insights to help improve lifestyles of people across the world”.
The company has been revenue positive in year one and is now on-track to achieve a 4-5 times growth in revenues this financial year. The investment will allow Human Edge to streamline their platform through its first enterprise-wide mobile app experience targeted directly at the white collar employees. Further, the company will scale up their sales in the international market by targeting global corporations. Ashika Capital was an advisor to Human Edge in this process.
“The simple focus of our efforts is on democratizing health by facilitating each of us to live at our most optimal self, moving beyond the more traditional disease focused outcomes. We, at Human Edge, chose to focus on energy as each of us would like to optimize our energy levels each day to achieve the goals we set out for ourselves”, says Marcus Ranney, Founder & CEO, Human Edge. “From a biological perspective, energy production and consumption are critical towards our cellular health. The understanding of the status of the powerhouse of our cells, our Mitochondria, is increasingly growing and being linked to the development of chronic diseases ranging from metabolic syndrome to cardiovascular diseases. As we optimize energy, we enhance mitochondrial activity and can help a person stay healthy as long as possible”.